ThinkSabio

$RVMD

$188.12▲ -6.3% YTD

11 SEC 13D/G filings tracked · Last updated Oct 8, 2026

Filing History
News
RVMD ▼ -6.3% - Revolution Medicines, Inc.
CP $188.12▲ -6.3%Oct 8, 2026 · ThinkSabio Blog

$RVMD RBC Capital notes Revolution Medicines looks to be down in response to yesterday's disclosure of FDA's Rasonque review documents, particularly t…

News
RVMD ▼ -6.3% - Revolution Medicines, Inc.
CP $188.12▲ -6.3%Oct 8, 2026 · ThinkSabio Blog

$RVMD Truist recommends using today's selloff in shares of Revolution Medicines as a buying opportunity. The firm attributes the pullback to newly dis…

News
RVMD ▲ +0.4% - Revolution Medicines, Inc.
CP $207.50▲ +0.4%Oct 5, 2026 · ThinkSabio Blog

$RVMD - Revolution Medicines Begins Treating Patients in Phase 3 RASolute 309 Trial Evaluating RASONQUE™ (daraxonrasib) Plus Zoldonrasib as First-Line…

News
RVMD ▼ -0.6% - Revolution Medicines, Inc.
CP $203.93▲ -0.6%Sep 15, 2026 · ThinkSabio Blog

$RVMD - zoldonrasib Receives orphan drug designation…

News
RVMD ▼ -1.5% - Revolution Medicines, Inc.
CP $200.71▲ -1.5%Sep 14, 2026 · ThinkSabio Blog

$RVMD - Revolution Medicines Announces U.S. FDA Breakthrough Therapy Designation for RASONQUE™ (daraxonrasib) in Combination with Chemotherapy for Fir…

News
RVMD ▲ +1.0% - Revolution Medicines, Inc.
CP $209.81▲ +1.0%Sep 10, 2026 · ThinkSabio Blog

$RVMD RevMed Rated New Buy at Morgan Stanley on Oncology Drug Upside, PT $255…

News
RVMD ▼ -0.3% - Revolution Medicines, Inc.
CP $209.23▲ -0.3%Sep 2, 2026 · ThinkSabio Blog

$RVMD - New England Journal of Medicine Publishes Phase 1/2 Clinical Data on Revolution Medicines’ RASONQUE™ (daraxonrasib) in Metastatic Non-Small Ce…

News
RVMD ▲ +3.3% - Revolution Medicines, Inc.
CP 222.50▲ +3.3%Aug 27, 2026 · ThinkSabio Blog

$RVMD Evercore 320 from 230 HCW 280 from 195…

SEC 13D/G
RVMD - Revolution Medicines, Inc. - SEC Filing Update (13-AUG-2026) | ThinkSabio - Stocks Simplified
$202.00▲ 155.70%Aug 13, 2026 · ThinkSabio Blog

$RVMD SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #RVMD Revolution Medicines, Inc. : $202.00 Sector: Healthcare |…

SEC 13D/G
RVMD - Revolution Medicines, Inc. - SEC Filing Update (13-AUG-2026) | ThinkSabio - Stocks Simplified
$203.73▲ 157.89%Aug 13, 2026 · ThinkSabio Blog

$RVMD SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #RVMD Revolution Medicines, Inc. : $203.73 Sector: Healthcare |…

SEC 13D/G
$RVMD SEC Filing Update (29-JUL-2026) | ThinkSabio - Stocks Simplified
$181.52▲ 129.77%Jul 29, 2026 · ThinkSabio Blog

$RVMD SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #RVMD : $181.52 Sector: Healthcare | YTD: 🔼+ 129.77% The SEC dis…